No Data
No Data
Insider Sale: EVP & Chief Financial Officer of $COLL Sells 6,396 Shares
Forecasting The Future: 4 Analyst Projections For Collegium Pharmaceutical
Express News | HC Wainwright & Co. Reiterates Buy on Collegium Pharmaceutical, Maintains $50 Price Target
Collegium Pharmaceutical Analyst Ratings
Collegium Pharmaceutical: Undervalued Stock With Strong Growth Potential and Low Risk
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.